Ignite Creation Date:
2025-12-24 @ 6:34 PM
Ignite Modification Date:
2026-01-07 @ 10:28 PM
Study NCT ID:
NCT02120157
Status:
COMPLETED
Last Update Posted:
2021-11-26
First Post:
2014-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-16
First Submit QC Date:
None
Study First Post Date:
2014-04-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-28
Results First Submit QC Date:
None
Results First Post Date:
2019-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-23
Last Update Post Date:
2021-11-26
Last Update Post Date Type:
ACTUAL